The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer The Hedgehog (Hh) signaling pathway is critical for cell growth and differentiation during embryogenesis and ...

The panel examine toxicity and morbidity considerations for the use of hedgehog pathway inhibitors in BCC. This is a video synopsis/summary of a Peer Exchange involving Jason Luke, MD, FACP; ...

Promising results from a phase 2 trial of ENV-101, a novel hedgehog inhibitor, showed improvement in lung function and reduction of fibrosis in patients with idiopathic pulmonary fibrosis, said Paul ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, ...

Chengdu Sibeibo Pharmaceutical Technology Co. Ltd. has divulged deuterated derivatives of taladegib acting as Hedgehog signaling inhibitors and protein smoothened (SMO) antagonists reported to be ...

Co announces that Infinity has regained from MedImmune, which is wholly owned by AstraZeneca (AZN), all development and worldwide commercialization rights for Infinity's Hedgehog cell-signaling ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...